Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Julie So-Young Kim
CEOJulie So-Young Kim
Employees
47,029
Employees47,029
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,029
Employees47,029

TAK Key Statistics

Market cap
61.27B
Market cap61.27B
Price-Earnings ratio
-57.57
Price-Earnings ratio-57.57
Dividend yield
3.06%
Dividend yield3.06%
Average volume
2.37M
Average volume2.37M
High today
$19.05
High today$19.05
Low today
$18.81
Low today$18.81
Open price
$18.86
Open price$18.86
Volume
71.33K
Volume71.33K
52 Week high
$19.10
52 Week high$19.10
52 Week low
$12.99
52 Week low$12.99

TAK News

Benzinga 1d
Full Transcript: Takeda Pharmaceutical Co Q1 2026 Earnings Call - Benzinga

...

Full Transcript: Takeda Pharmaceutical Co Q1 2026 Earnings Call - Benzinga
TipRanks 4d
Takeda announces FDA acceptance of zasocitinib under priority review

Takeda (TAK) announced that the FDA accepted its new drug application, or NDA, under priority review for zasocitinib for the treatment of adults with moderate-t...

TipRanks 4d
Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care

Takeda Pharmaceutical Co ( (JP:4502) ) just unveiled an update. Takeda has secured U.S. FDA Priority Review for its New Drug Application for zasocitinib, an or...

Analyst ratings

59%

of 17 ratings
Buy
58.8%
Hold
41.2%
Sell
0%

More TAK News

TipRanks 7d
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Takeda tracks real world use of OBIZUR in adults with acquired hemophi...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.